West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
320.88
+9.22 (2.96%)
Nov 21, 2024, 4:00 PM EST - Market closed
WST Revenue
West Pharmaceutical Services had revenue of $746.90M in the quarter ending September 30, 2024, a decrease of -0.07%. This brings the company's revenue in the last twelve months to $2.88B, down -1.71% year-over-year. In the year 2023, West Pharmaceutical Services had annual revenue of $2.95B with 2.18% growth.
Revenue (ttm)
$2.88B
Revenue Growth
-1.71%
P/S Ratio
7.94
Revenue / Employee
$271,358
Employees
10,600
Market Cap
23.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
Dec 31, 2019 | 1.84B | 122.50M | 7.13% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Koninklijke Philips | 20.12B |
Biogen | 9.61B |
Zimmer Biomet Holdings | 7.60B |
STERIS | 5.33B |
Illumina | 4.39B |
Mettler-Toledo International | 3.76B |
BioNTech SE | 3.39B |
BeiGene | 3.35B |
WST News
- 14 days ago - 17 Upcoming Dividend Increases - Seeking Alpha
- 23 days ago - West to Participate in Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - West Pharmaceutical Services, Inc. (WST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend - Benzinga
- 4 weeks ago - West Pharmaceutical raises annual profit forecast on demand for medical supplies - Reuters
- 4 weeks ago - West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend - PRNewsWire
- 4 weeks ago - West to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA Conference - PRNewsWire
- 6 weeks ago - West to Host Third-Quarter 2024 Conference Call - PRNewsWire